“…Symptoms can manifest in multiple ways at various points along the survivorship trajectory depending on the nature of the cancer, the treatments administered, and the unique characteristics of the individual. Symptoms to be managed following completion of primary cancer treatment can include, but are not limited to: fatigue (Bower, 2008; Carlson & Speca, 2007; Lemieux, Bordeleau, & Goodwin, 2007; Minton & Stone, 2008; Ng, Alt, & Gore, 2007); pain and peripheral neuropathies (Aksnes & Bruland, 2007; Beatty, Oxlad, Koczwara, & Wade, 2008; Chang & Sekine, 2007; Sullivan, Thibault, Savard, & Velly, 2007); taste changes, anorexia, malnutrition, nausea and vomiting (Beatty et al, 2008; Ganz, 2009); vaginal dryness, peri-menopausal or male menopausal symptoms and fertility issues (Bordeleau et al, 2010; Beatty et al, 2008; Ganz et al, 2011; Jacobs et al, 2007; Lemieux et al, 2007); psychological distress, post-traumatic stress symptoms, and anxiety (Henselmans et al, 2010; Jim & Jacobsen, 2008; Kornblith & Ligibel, 2003; Nezu & Nezu, 2007; Roberts & Clarke, 2009), sleep disturbances (Bower, 2008; Carlson & Speca, 2007); cognitive disturbances and mild cognitive impairment (Bower, 2008; Correa & Ahles, 2008; Ferguson, Riggs, Ahles, & Saykin, 2007; Jacobs et al, 2007; Marin, Sanchez, Arranz, Aunon, & Baron, 2009); abnormal weight gain and night sweats (Befort & Klemp, 2011; Halbert, Weathers, Esteve, Audrain-McGovern, Kumanyika, DeMichele & Barg, 2008; Jacobs et al, 2007); urinary symptoms and changes in sexual function (Ganz, 2009; Jacobs et al, 2007); cardiac toxicities and symptoms of other chronic illnesses exacerbated or caused by treatment (Lemieux et al, 2007; Prosnitz, Chen, & Marks, 2005; Rozenberg, Antoine, Carly, Pastijn, & Liebens, 2007); and symptoms of musculoskeletal changes caused by the cancer or cancer treatments, such as fibrosis, muscle atrophy and deformity, lymphedema, cancer-treatment induced bone loss (Aksnes & Bruland, 2007; Beatty et al, 2008; Camp-Sorrell, 2009; Rozenberg et al, 2007). Often survivors will experience “symptom clusters” that can add a greater level of complexity to the work of symptom management (Gaston-Johansson, Fall-Dickson, Bakos, & Kennedy, 1999).…”